COVID-19 vaccine hesitancy in Africa: a scoping review
Background Vaccination against the novel coronavirus is one of the most effective strategies
for combating the global Coronavirus disease (COVID-19) pandemic. However, vaccine …
for combating the global Coronavirus disease (COVID-19) pandemic. However, vaccine …
COVID-19 vaccine acceptance among low-and lower-middle-income countries: a rapid systematic review and meta-analysis
Widespread vaccination against COVID-19 is critical for controlling the pandemic. Despite
the development of safe and efficacious vaccinations, low-and lower-middle income …
the development of safe and efficacious vaccinations, low-and lower-middle income …
Predictors of COVID-19 vaccine hesitancy in South African local communities: the VaxScenes study
South Africa launched a mass COVID-19 vaccination campaign in May 2021, targeting 40
million adults. Understanding predictors of COVID-19 vaccine intentions was required to …
million adults. Understanding predictors of COVID-19 vaccine intentions was required to …
Persisting vaccine hesitancy in Africa: the whys, global public health consequences and ways-out—COVID-19 vaccination acceptance rates as case-in-point
Vaccine hesitancy (VH) is the seventh among the WHO's top 10 threats to global public
health, which has continued to perpetuate the transmission of vaccine preventable diseases …
health, which has continued to perpetuate the transmission of vaccine preventable diseases …
COVID-19 vaccine demand and financial incentives
Background Public health experts estimate that only very high COVID-19 vaccine uptake
levels can result in herd immunity. Objective This study's main objective was to evaluate the …
levels can result in herd immunity. Objective This study's main objective was to evaluate the …
[HTML][HTML] Willingness-to-pay for COVID-19 vaccine in ten low-middle-income countries in Asia, Africa and South America: A cross-sectional study
Vaccine hesitancy is considered as one of the greatest challenges to control the ongoing
coronavirus disease 2019 (COVID-19) pandemic. A related challenge is the unwillingness of …
coronavirus disease 2019 (COVID-19) pandemic. A related challenge is the unwillingness of …
Covid-19 vaccine acceptance and determinant factors among general public in East Africa: a systematic review and meta-analysis
A Alemayehu, A Demissie, M Yusuf… - Health services …, 2022 - journals.sagepub.com
Background Vaccines are an effective and ideal solution that can reduce the burden of
disease worldwide. Although vaccines are the most effective way to prevent infectious …
disease worldwide. Although vaccines are the most effective way to prevent infectious …
COVID-19 vaccine acceptance and associated factors in 13 African countries: A systematic review and meta-analysis
J Azanaw, M Endalew, D Zenbaba, E Abera… - Frontiers in Public …, 2023 - frontiersin.org
Background The COVID-19 pandemic has severely affected the entire world, especially sub-
Saharan Africa. As a result, researchers and government agencies are working to create …
Saharan Africa. As a result, researchers and government agencies are working to create …
Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects
Z Fang, J Lyu, J Li, C Li, Y Zhang, Y Guo… - … in Bioengineering and …, 2022 - frontiersin.org
Bioreactors are widely used in cell culture-based viral vaccine production, especially during
the coronavirus disease 2019 (COVID-19) pandemic. In this context, the development and …
the coronavirus disease 2019 (COVID-19) pandemic. In this context, the development and …
Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
HJ Zhou, L Pan, H Shi, JW Luo, P Wang… - Frontiers in …, 2022 - frontiersin.org
Objective: The present study aims to assess the willingness to pay (WTP) for and willingness
to vaccinate (WTV) with the Coronavirus (COVID-19) vaccine booster dose in China when …
to vaccinate (WTV) with the Coronavirus (COVID-19) vaccine booster dose in China when …